Mitsubishi Gas Chemical Company (4182) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
16 Feb, 2026Executive summary
Net sales decreased 6.2% year-over-year to ¥583.2 billion, mainly due to the transition of JSP Corporation to an equity-method affiliate, despite positive factors like yen depreciation and higher sales of optical polymers for smartphones.
Operating profit rose 17.2% to ¥45.3 billion, driven by growth in Specialty Chemicals and yen depreciation.
Ordinary profit increased 24.1% to ¥53.9 billion, supported by higher methanol prices and improved equity in earnings of affiliates.
Profit attributable to owners of parent fell 11.1% to ¥35.6 billion, reflecting the absence of a prior-year gain from step acquisitions.
Financial highlights
Net sales: ¥583.2 billion (down 6.2% year-over-year).
Operating profit: ¥45.3 billion (up 17.2% year-over-year).
Ordinary profit: ¥53.9 billion (up 24.1% year-over-year).
EPS: ¥178.18 (down from ¥196.18 year-over-year).
Gross profit for the nine months was ¥129.3 billion, down from ¥137.4 billion year-over-year.
Outlook and guidance
Full-year forecasts for operating profit and ordinary profit remain unchanged at ¥56.0 billion and ¥63.0 billion, respectively.
Net sales forecast for FY2024 is ¥770.0 billion, with profit attributable to owners of parent at ¥48.0 billion.
Annual dividend forecast is ¥95.00 per share, up from ¥80.00 in the previous year.
Assumed FX rates revised to ¥152/USD and ¥160/EUR for the remainder of the year.
Methanol market price projected to rise in 4Q due to supply constraints.
Latest events from Mitsubishi Gas Chemical Company
- Operating profit more than doubled on strong specialty chemicals demand and yen depreciation.4182
Q1 202516 Feb 2026 - Operating profit surged 52.7% year-over-year, driven by Specialty Chemicals growth.4182
Q2 202516 Feb 2026 - Operating profit up 7.4% despite 4.9% sales drop; FY2025 outlook cautious.4182
Q4 202516 Feb 2026 - Profits fell on weak chemical markets and FX volatility, but sales forecast was raised.4182
Q1 202616 Feb 2026 - Profits fell on lower prices and impairments, but dividend forecast raised to ¥100 per share.4182
Q3 202616 Feb 2026 - Impairment loss and weak markets drive lower profits and a revised net loss outlook for FY2025.4182
Q2 202616 Feb 2026